Abiomed, Inc. (ABMD) Posts Surprise Q4 Profit; Guides FY12 Revs Above

May 18, 2011 7:02 AM EDT
Abiomed, Inc. (Nasdaq: ABMD) reported Q4 EPS of $0.01, $0.05 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $28.5 million versus the consensus estimate of $27.71 million.

Sees FY12 revenue of $120 - $125 million, versus the consensus of $119.36 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Hot Guidance